US Drug Recall Register

FDA Drug Recalls

14,801 recalls, newest first

Class I · High risk Terminated

Leafree Instant Hand Sanitizer Aloe Vera

Reason Marketed without an Approved NDA/ANDA; product labeled as Edible Alcohol rendering the product an unapproved new drug and misbranded.

Corgiomed LLC D-1586-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations

Preferred Pharmaceuticals, Inc. NDC 68788-7605-09 D-1624-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations

Preferred Pharmaceuticals, Inc. NDC 68788-7604-09 D-1623-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations

Preferred Pharmaceuticals, Inc. NDC 68788-6860-09 D-1622-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations

Preferred Pharmaceuticals, Inc. NDC 68788-9283-01 D-1621-2020
Class II · Moderate risk Terminated

Hand Sanitizer

Reason CGMP Deviations: Product contains acetaldehyde and acetal above the allowable limits.

Charles Paint Research Inc D-0792-2021
Class II · Moderate risk Terminated

Hand Sanitizer

Reason CGMP Deviations: Product manufactured in same facility where product was found to contain acetaldehyde and acetal above the allowable limits.

Charles Paint Research Inc D-0791-2021
Class I · High risk Terminated

Red-E Tablet

Reason Marketed Without An Approved NDA/ANDA: product found to be tainted with sildenafil, an FDA approved drug for the treatment of male erectile dysfunction, making this an unapproved drug fro which the safety and efficacy have not been established and therefore subject to recall.

The Protein Shoppe D-1595-2020
Class I · High risk Terminated

Nature Throid

Reason Subpotent Drug: FDA analysis found product to be subpotent

RLC Labs Inc. NDC 64727-3305-4 D-1619-2020
Class I · High risk Terminated

Nature Throid

Reason Subpotent Drug: FDA analysis found product to be subpotent

RLC Labs Inc. NDC 64727-3308-4 D-1618-2020
Class I · High risk Terminated

Nature Throid

Reason Subpotent Drug: FDA analysis found product to be subpotent

RLC Labs Inc. NDC 64727-3303-1 D-1617-2020
Class I · High risk Terminated

Nature Throid

Reason Subpotent Drug: FDA analysis found product to be subpotent

RLC Labs Inc. NDC 64727-3302-1 D-1616-2020
Class I · High risk Terminated

Nature Throid

Reason Subpotent Drug: FDA analysis found product to be subpotent

RLC Labs Inc. NDC 64727-3299-6 D-1615-2020
Class I · High risk Terminated

WP Thyroid

Reason Subpotent Drug: FDA analysis found product to be subpotent

RLC Labs Inc. NDC 64727-5550-4 D-1614-2020
Class II · Moderate risk Terminated

WP Thyroid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-5950-2 D-1613-2020
Class II · Moderate risk Terminated

WP Thyroid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-6150-2 D-1612-2020
Class II · Moderate risk Terminated

WP Thyroid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-5850-2 D-1611-2020
Class II · Moderate risk Terminated

WP Thyroid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-6050-2 D-1610-2020
Class II · Moderate risk Terminated

WP Thyroid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-5750-2 D-1609-2020
Class II · Moderate risk Terminated

WP Thyroid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-5650-2 D-1608-2020
Class II · Moderate risk Terminated

WP Thyroid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-5550-2 D-1607-2020
Class II · Moderate risk Terminated

WP Thyroid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-5450-4 D-1606-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3312-4 D-1605-2020
Class II · Moderate risk Terminated

Nature-Throid

Reason CGMP Deviations: manufactured under the same conditions as those found to be subpotent.

RLC Labs Inc. NDC 64727-3310-4 D-1604-2020